SOFINICLINE (ABT-894 ) FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-def icit/hyperactivity disorder.

Saved in:
Bibliographic Details
Main Authors BAIN, EARLE E, AWNI, WALID M, GARIMELLA, TUSHAR S, ABI-SAAB, WALID M, SALTARELLI, MARIO D, DUTTA, SANDEEP
Format Patent
LanguageEnglish
French
Published 10.12.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-def icit/hyperactivity disorder.
Bibliography:Application Number: CA20092725470